Scalper1 News
Specialty drug maker Horizon Pharma (HZNP) tried to continue its recent acquisition binge Tuesday as it made a hostile all-stock offer for Depomed (DEPO) worth roughly $3 billion, including debt. Depomed stock jumped nearly 40% on the news to a record high, while Horizon Pharma stock, which touched its all-time high on Wednesday, was down 2.5%. Horizon offered $29.25 a share for Depomed, a 42% premium on Monday’s closing price. Horizon’s Scalper1 News
Scalper1 News